Patent details

Basic Information

Publication number:

EP2305282

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP101825750

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Prevention and treatment of amyloidogenic disease

French Title of Invention:

Prévention et traitement de maladie amyloidogène

German Title of Invention:

Vorbeugung und Behandlung von amyloidogener Krankheit

SPC Number:

Dates

Filing date:

30/11/1998

Grant date:

10/07/2013

EP Publication Date:

10/07/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/04/2011

EP B1 Publication Date:

10/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

30/11/2018

Renunciation date:

Revocation date:

09/11/2016

Annulment date:

Owner

From:

30/11/1998

 

 

Name:

Janssen Alzheimer Immunotherapy

Address:

Airton Road Tallaght, Dublin 24, Ireland (IE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/07/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

Schenk Dale B.

Address:

United States (US)

Priority

1

Priority Number:

67740 P

Priority Date:

02/12/1997

Priority Country:

United States (US)

2

Priority Number:

80970 P

Priority Date:

07/04/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/11/2016

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages